Cipla rises as its UK subsidiary enters into JVA with Cooper Pharma, PHI

10 Feb 2015 Evaluate

Cipla is currently trading at Rs. 631.80, up by 2.15 points or 0.34% from its previous closing of Rs. 629.65 on the BSE.

The scrip opened at Rs. 631.00 and has touched a high and low of Rs. 636.15 and Rs. 628.15 respectively. So far 30571 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 711.45 on 29-Jan-2015 and a 52 week low of Rs. 366.70 on 24-Feb-2014.

Last one week high and low of the scrip stood at Rs. 700.00 and Rs. 626.10 respectively. The current market cap of the company is Rs. 50558.40 crore.

The promoters holding in the company stood at 36.80%, while Institutions and Non-Institutions held 35.31% and 26.16% respectively.

Cipla’s - wholly owned subsidiary, Cipla (EU), UK has entered into a joint venture agreement (JVA) with Cipla’s existing business partners in Morocco - Societe Marocaine De Cooperation Pharmaceutique (Cooper Pharma) and The Pharmaceutical Institute (PHI). Cipla has established a strong presence in Morocco for over a decade via its business partners.

This JV will enable Cipla to establish a front-end presence in Morocco’s pharmaceutical market, becoming the launch vehicle for Cipla’s portfolio while leveraging the commercial strengths of partners. The initial focus of the JV shall be respiratory and neurology products and it shall also invest in setting up a manufacturing facility in Morocco.

As per the agreement, Cipla (EU) will hold 60% stake in the JV, while Cooper Pharma and PHI shall together hold 40% stake. Cipla (EU)’s expected investment in cash in the JV is estimated at up to $15 million. The transaction remains subject to conditions precedent and applicable regulatory approvals.

 

Cipla Share Price

1510.90 19.50 (1.31%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×